Sunesis Pharmaceuticals
| Region | Nordamerika |
| ISIN | US8673288747 |
| Sektor | Biotechnologie |
| Website | https://www.sunesis.com/ |
Sunesis is a clinical-stage biopharmaceutical company focused on the development and commercialization of new oncology therapeutics. With a passion to advance novel drugs, we are inspired to make a difference in cancer patients' lives.
| Titel | Autor | Datum |
|---|---|---|
|
Risikoarmes "Peak Play" mit Multibagger-Potenzial
|
sharedeals | vor ungefähr einem Jahr |
| Titel | Datum |
|---|---|
| MISC's AET takes delivery of first of three DP2 shuttle tankers for Shell charter | vor 11 Tagen |
| MAHB, Serba Dinamik, Pharmaniaga, MISC, Syarikat Takaful, TDM, Cypark, Tuju Setia, Inta Bina, WZ Satu, SMTrack, Poh Huat, Sarawak Cable | vor 17 Tagen |
| Tengku Marina Tunku Annuar joins MISC board as independent director | vor 17 Tagen |
| MISC poised to print an uptrend movement, says RHB Retail Research | vor ungefähr einem Monat |
| MISC Berhad debuts on DJSI Emerging Markets Index | vor ungefähr 2 Monaten |
| Diese Aktien könnten Dich auch interessieren | |
|---|---|
| Suedzucker (1 Artikel) | |
| Stockholm IT Ventures AB (1 Artikel) | |
| Tahoe Resources (1 Artikel) | |
| Telit Communications (3 Artikel) | |
| Alle anzeigen | |